Your account is not claimed yet. You can sign up with ORCID to claim your account.

Hendrick-Tobias Arkenau (Tobias Arkenau, Hendrik-Tobias Arkenau)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Venues

Cancers

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO precision oncology

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Mark J Roschewski, Manish R Patel, Patrick M Reagan, Nakhle S Saba, Graham P Collins, Hendrick-Tobias Arkenau, Sven de Vos, Barret R B Nuttall, Melih Acar, Kathleen Burke, Rafael D White, Maria Udriste, Shringi Sharma, Brian Dougherty, Daniel Stetson, David F Jenkins, Andrew Mortlock, Alessandra Forcina, Veerendra Munugalavadla, Ian W Flinn
Phase 1 Study of Acalabrutinib Plus Danvatirsen (AZD9150) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Including Circulating Tumor DNA Biomarker Assessment. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Nataliya Mar, Yousef Zakharia, Alejandro Falcon, Rafael Morales-Barrera, Begona Mellado, Ignacio Duran, Do-Youn Oh, Stephen K Williamson, Pablo Gajate, Hendrick-Tobias Arkenau, Robert J Jones, Min Yuen Teo, Tolga Turan, Robert T McLaughlin, Hillary M Peltier, Elizabeth Chong, Harisha Atluri, James P Dean, Daniel Castellano
Results from a Phase 1b/2 Study of Ibrutinib Combination Therapy in Advanced Urothelial Carcinoma. Cancers 15 (11) (2023)
Robert Jones, Ruth Plummer, Victor Moreno, Louise Carter, Desamparados Roda, Elena Garralda, Rebecca S Kristeleit, Debashis Sarker, Hendrick-Tobias Arkenau, Patricia Roxburgh, Harriet Sarah Walter, Sarah P Blagden, Alan Anthony, Barbara J Klencke, Mark M Kowalski, Udai Banerji
A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Lin Shen, Ken Kato, Sung-Bae Kim, Jaffer A Ajani, Kuaile Zhao, Zhiyong He, Xinmin Yu, Yongqian Shu, Qi Luo, Jufeng Wang, Zhendong Chen, Zuoxing Niu, Longzhen Zhang, Tienan Yi, Jong-Mu Sun, Jianhua Chen, Guohua Yu, Chen-Yuan Lin, Hiroki Hara, Qing Bi, Taroh Satoh, Roberto A Pazo-Cid, Hendrick-Tobias Arkenau, Christophe Borg, Florian Lordick, Liyun Li, Ningning Ding, Aiyang Tao, Jingwen Shi, Eric Van Cutsem, null null
Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (26) (2022)
Jordi Rodon Ahnert, Pauline Funchain, Theodore W Laetsch, Hendrick-Tobias Arkenau, Alice Hervieu, Christian F Singer, Yonina R Murciano-Goroff, Sant P Chawla, Kristin Anthony, Ikuo Yamamiya, Mei Liu, Abdel-Baset Halim, Karim A Benhadji, Osamu Takahashi, Suzette Delaloge
A phase II study of TAS-117 in patients with advanced solid tumors harboring germline PTEN -inactivating mutations. Future oncology (London, England) 18 (30) (2022)
Cristina Morelli, Michela Rofei, Silvia Riondino, Daniela Fraboni, Francesco Torino, Augusto Orlandi, Manfredi Tesauro, Giovanna Del Vecchio Blanco, Massimo Federici, Hendrick-Tobias Arkenau, Vincenzo Formica, Mario Roselli
Immune Response in Vitamin D Deficient Metastatic Colorectal Cancer Patients: A Player That Should Be Considered for Targeted Vitamin D Supplementation. Cancers 14 (11) (2022)
Elisa Fontana, Gonzalo Torga, Raluca Maria Fostea, Susan Cleator, Ernesto Wasserman, Anastasia Murat, Hendrick-Tobias Arkenau
Sustained Tumor Regression With Zenocutuzumab, a Bispecific Antibody Targeting Human Epidermal Growth Factor Receptor 2/Human Epidermal Growth Factor Receptor 3 Signaling, in NRG1 Fusion-Positive, Estrogen Receptor-Positive Breast Cancer After Progression on a Cyclin-Dependent Kinase 4/6 Inhibitor. JCO precision oncology 6 (2022)
Ian Chau, Nicolas Penel, Andres O Soriano, Hendrick-Tobias Arkenau, Jennifer Cultrera, Rafael Santana-Davila, Emiliano Calvo, Christophe le Tourneau, Lars Zender, Johanna C Bendell, Gu Mi, Ling Gao, Samuel Clark McNeely, Joana M Oliveira, David Ferry, Roy S Herbst, Charles S Fuchs
Ramucirumab in Combination with Pembrolizumab in Treatment-Naïve Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF Trial. Cancers 12 (10) (2020)
Raluca Maria Fostea, Elisa Fontana, Gonzalo Torga, Hendrick-Tobias Arkenau
Recent Progress in the Systemic Treatment of Advanced/Metastatic Cholangiocarcinoma. Cancers 12 (9) (2020)

Hendrick-Tobias Arkenau.css-eqlu8i{font-size:small;padding-left:4px;} (Tobias Arkenau, Hendrik-Tobias Arkenau)

Publication Activity (10 Years)

Top Topics

Top Venues

Hendrick-Tobias Arkenau (Tobias Arkenau, Hendrik-Tobias Arkenau)